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ABSTRACT
The chicken spinal cord is an excellent model for the
study of early neural development in vertebrates.
However, the lack of robust, stable and versatile
transgenic methods has limited the usefulness of
chick embryos for the study of later neurodeve-
lopmental events. Here we describe a new
transgenic approach utilizing the PiggyBac (PB)
transposon to facilitate analysis of late-stage
neural development such as axon targeting and
synaptic connection in the chicken embryo. Using
PB transgenic approaches we achieved temporal
and spatial regulation of transgene expression and
performed stable RNA interference (RNAi). With
these new capabilities, we mapped axon projection
patterns of V2b subset of spinal interneurons
and visualized maturation of the neuromuscular
junction (NMJ). Furthermore, PB-mediated RNAi in
the chick recapitulated the phenotype of loss of
agrin function in the mouse NMJ. The simplicity
and versatility of PB-mediated transgenic strategies
hold great promise for large-scale genetic analysis
of neuronal connectivity in the chick.
INTRODUCTION
The vast diversity of neuronal cell types exhibiting
highly complex synapses present signiﬁcant challenges to
deﬁning molecular mechanisms that promote assembly of
speciﬁc synaptic connectivity in the vertebrate central
nervous system. Unlike genetic powerhouses such as
Drosophila melanogaster and Caenorhabditis elegans, ver-
tebrate model organisms largely lack appropriate genetic
tools to analyze neuronal connectivity. Recent pioneering
studies demonstrated the feasibility and utility of analyzing
neuronal connectivity using ﬂuorescent protein-labeled
genetic mosaics in mice (1–5). However, these approaches
require generating individual transgenic mouse lines and
therefore are not amenable to high-throughput analysis.
The chicken embryo has been widely used for studying
early embryogenesis because of its ready availability and
accessibility to various manipulations (6). During the past
decade, in ovo electroporation and avian recombinant
retrovirus expression systems have signiﬁcantly contri-
buted to rapid progress in the understanding of early
neural developmental events such as neurogenesis, pat-
terning and migration (7–13). By contrast, progress in
the analysis of late development of axon targeting and
synapse formation has been somewhat less due to techni-
cal limitations with these approaches. To overcome these
limits and to increase the throughput of genetic analysis in
the chicken embryo, we aimed at developing a simple,
eﬃcient and stable transgenic approach to study gene
function in the developing chicken spinal cord.
PiggyBac (PB) is a highly eﬃcient transposon originally
isolated from Trichoplusia ni (14). PB has been subse-
quently shown to be functional in many diﬀerent species
including ﬂy and mouse (15,16). The precise ‘cut and
paste’ transposition mechanism makes PB a powerful
tool for mutagenesis and transgenic manipulation
(16–22). Unlike recombinant retroviral systems, PB can
accommodate relatively large DNA fragments without
compromising transposition eﬃciency (16). In addition,
PB has two potential advantages over other transposon
systems such as Sleep Beauty (SB) and Tol2. First, PB
exhibits signiﬁcantly higher transposition eﬃciency in
mammalian cells (23). Second, multiple copies of PB can
incorporate into the host genome (16,21) providing for
the possibility of multiple simultaneous manipulations of
the host genome. For these reasons, we decided to develop
PB-mediated transgenic approaches to facilitate the
analysis of neuronal connectivity in the spinal cord.
Here we show that, in combination with in ovo electro-
poration, PB-mediated transgenics is highly eﬃcient for
the chicken embryo. PB transgenic approaches are com-
patible with heterologous promoters and Cre/loxP tech-
nology that enable temporal control of transgene
expression and cell-type-speciﬁc labeling. In addition, PB
transgenes stably express small hairpin RNAs (shRNAs)
that enable robust loss of function analysis to be per-
formed in the chick. As proof of principle, we recapitulate
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agrin mutant mice using shRNAs in the chick. Thus, PB
transgenics is an eﬃcient and versatile approach that can
be used for large-scale circuit mapping and functional
analysis of the vertebrate nervous system.
MATERIALS AND METHODS
Plasmid construction
All expression vectors used in this study were constructed
by cloning restriction enzyme digested or PCR ampliﬁed
DNA fragments with standard protocol. Fireﬂy and
Renilla luciferase expression vectors were originally
obtained from Promega. EGFP, destabilized GFP and
DsRed vectors were derived from Clontech (pEGFP-N1,
pd2EGFP, pDsRedN2). The PiggyBac and PBase
expressing vectors were described previously (21).
pCYL50, a PB vector containing multiple cloning sites,
was used as the parental plasmid to construct all PB
derivatives. Annealed double strand oligos encoding
shRNAs were cloned downstream of human H1
promoter between BbsI and XhoI sites in a PB vector.
To construct CMV-Fﬂuc-agrin reporter, a 650bp cDNA
fragment corresponding to the shared exons of alterna-
tively spliced chicken agrin transcripts was ampliﬁed
by RT-PCR from HH 30 chicken neuronal RNAs. This
agrin cDNA fragment was then digested with EcoRI and
NotI within the primer sequences and cloned into a CMV-
Fﬂuc vector. All vectors in this study are summarized in
Supplementary Table S1. All cloning was veriﬁed by
complete or partial sequencing.
Cell culture and transfection
DF-1 chicken ﬁbroblast cells were maintained in
Dulbecco’s Modiﬁed Eagle’s Medium with 10% fetal
bovine serum. Cells were transfected with Lipofectamine
2000 (Invitrogen). To test the relative knockdown eﬃ-
ciency of agrin shRNAs, DF-1 cells in a 24-well plate
were cotransfected with CMV-Ff-luc-agrin reporter
(0.3mg per well), Renilla luc (0.1mg per well) and individ-
ual eﬀector shRNAs (0.3mg per well) against chicken
agrin. For luciferase assay, transfected cells were
passaged every 2 days and harvested in passive lysis
buﬀer (PLB, Promega).
Splinkerette PCR
To identify PB transposition sites in chicken cells, DF-1
cells were transfected with PB-PGK-Hyg and PBase at
a ratio of 2:1in six-well plates using Lipofectamine 2000
protocol. Twenty-four hours after transfection, 5 10
4
cells were plated on 10cm dish with Hygromycin
(300mg/ml) selection until visible clones were growing.
Genomic DNA was prepared from individual clones and
Splinkerette PCR was performed as described previously
(21,24). Unique PCR products were TA-cloned for
sequencing.
Chicken embryo electroporation
In ovo electroporation was performed as previously
described (25,26). In brief, fertilized white leghorm
chicken eggs were incubated at 38 C until HH stage12
prior to electroporation. Mixtures of plasmids were
injected into the central canal of the neural tube and
electroporation was performed in the thoracic segment
of spinal cord with 5 pulses at 25V, 50ms each. For
electroporation, endotoxin-free plasmid DNA (4mg/ml)
was mixed with 1/10 volume of fast green for micro-
injection. For PB transposition, a 2:1 ratio of transposon
and transposase was used in all experiments. For activa-
tion of ERT2CreERT2 transgene, 500ml 4-hydroxyta-
moxiphen (4-OHT, Sigma) at a concentration of
100mM was dropped on individual chicken embryos.
All electroporation experiments were repeated for at
least three times with multiple (6–12) chicken embryos.
Immunohistochemistry and in situ hybridization
For immunohistochemistry, chicken embryonic tissues
were dissected and ﬁxed for 2hin 4% paraformaldehyde.
After extensive PBS washes and cryo-protection with 30%
sucrose, samples were embedded in OCT and 12mm
cryostat sections were processed for indirect immunoﬂu-
orescence staining. The following primary antibodies were
used in this study: Mouse anti-GATA3 (1:100, Santa
Cruz), Rabbit anti-Myc (1:2000, Sigma), Mouse anti-
Flag M2 (1:2000, Sigma), Mouse anti-Islet1/2 (1:100,
DSHB), Mouse anti-GFAP (1:1000, Sigma), Rabbit
anti-LacZ (1:1000, Chemicon), Rabbit anti-GFP
(1:2000, Invitrogen) and Goat anti-luciferase (Promega).
In situ hybridization was performed as previously
described (27). A chicken agrin cDNA fragment was
cloned into the pCR4-TOPO vector and the antisense
riboprobe was labeled using digoxigenin-11-UTP
(Roche) with T7 RNA polymerase (Roche). Twenty
micrometer cryostat sections of shRNA celectroporated
chicken embryos were used for in situ hybridization,
and the hybridization signals were visualized with
POD-coupled anti-digoxigenin antibody (Roche) and
a ﬂuorescent substrate from a Cy3-TSA-plus kit
(Perkin Elmer).
Whole mount staining of NMJ
To visualize NMJ in gastrocnemius muscles, small muscle
bundles were dissected under ﬂuorescent microscope and
stained with a-bungatoxin conjugated with Texas Red
(1:5000, Molecular Probe) overnight at 4 C. Images
were captured on a Zeiss Confocal microscope PASCAL.
RESULTS
PB-mediated transgene expression in the developing
chicken spinal cord
To test the eﬃcacy of PB-mediated transposition in the
chicken cells, we cotransfected DF-1 chicken ﬁbroblast
cells with a PB transposon that expresses ﬁreﬂy luciferase
(PB-Ff) and a non-PB Renilla luciferase vector (CMV-Rn)
in the presence of the transposase helper plasmid
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1A). The PBase helper plasmid utilizes a CAG promoter
to ubiquitously express PBase in trans but itself is
transiently expressed at the time of transfection due to
the lack of the inverted repeats from PB transposon (21).
Dual luciferase assays showed that Ff/Rn luciferase ratios
in PBase-cotransfected cells dramatically increased after
several passages, demonstrating that PB-Ff was stably
integrated into the transfected cells whereas CMV-Rn
plasmid was lost over multiple cell divisions (Figure 1B).
Similar results were obtained with a PB version of Rn
luciferase and a non-PB Ff luciferase expression vectors
(data not shown). Because avian genomes have a very dif-
ferent evolutionary history comparing to mammals, we
used Splinkerette PCR to clone a small number of PB
transposition sites from stably transfected chicken DF-1
cells. Sequence analysis conﬁrmed that PB transposons
integrate at the same TTAA sequence in chicken cells
(Supplementary Table S2). Therefore, PB transposon sys-
tem can eﬃciently produce stably transfected chicken cells.
Figure 1. PB transposition in the chicken embryo. (A) Schematic of PB-Ff transposon and a non-PB control Rn vector. (B) Stable integration of
PB-Ff transposon in chicken DF-1 cells. A mixture of PB-Ff and Rn expression vectors was cotransfected into DF-1 cells with PBase or LacZ
control. At diﬀerent time points after transfection, relative ratios of Ff/Rn luciferase ratios were measured and plotted. All data points are repre-
sented as means±SEM (n=3). (C) Stable integration of PB-Ff transposon in the developing chicken spinal cord. The same experiment as in
(B) was performed with the developing chicken embryos (n = 3–4). Electroporated neural tubes were harvested for dual luciferase assay and the data
were analyzed as in (B). (D) Rapid expression of PB-GFP transgene in the chicken neural tube after electroporation. Shown are composite pictures of
GFP signals (green) and bright ﬁeld images. ‘S’ marks the somites and the yellow dotted line indicates the midline. (E) Whole mount view of a PB-
GFP labeled chicken embryo (E4) 2days after electroporation. The autoﬂuorescence is pseudo-colored in red to show the contour the embryo. GFP
is shown in green. (F) PB-GFP expression in the developing chicken spinal cord. Comparison of PB-GFP transgene expression with or without
PBase-mediated transposition. Robust and persistent GFP expression was seen in the chicken embryos that were coelectroporated with both PB-GFP
and PBase whereas GFP signals were quickly lost in the controls lacking of PBase. Green: anti-GFP staining. Bars: 50mm.
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transiently introduce transgenes into chicken embryos
(9). Thus, we next tested whether we could combine the
PB transposon with in ovo electroporation to perform
long-term transgenic studies in chicken embryos. The
chicken neural tubes were electroporated with PB-Ff and
CMV-Rn plasmids at stage 12 (around embryonic day 2).
The coexpression of PBase increased Ff/Rn ratios about
10-fold at later developmental stages (Figure 1C), suggest-
ing that PB transgenes are stably integrated into the host
genome.
To test whether higher luciferase activity results from
more expressing cells or a higher level of expression
per cell, we constructed a PB that expresses destabilized
GFP proteins. When co-introduced with PBase, the
electroporated chicken spinal cords were rapidly and
highly labeled with GFP (Figure 1D and E). At early
developmental stages, robust GFP labeling was seen in
both PB and non-PB transgenic embryos due to transient
transfection. The PB-GFP electroporated spinal cords
remained strongly labeled by GFP throughout embryonic
development, whereas few GFP labeled cells were present
in PBase-negative chicken embryos as development pro-
ceeded to later stages (Figure 1F). Although we routinely
obtain nearly 80–90% GFP-labeled cells 2 days after
electroporation, electroporation eﬃciency slightly varies
among individual embryos. To rule out the possibility
that the diﬀerence in electroporation eﬃciency might
have contributed to diﬀerent levels of destabilized GFP
observed in Figure 1F, we co-expressed Myc-tagged and
Flag-tagged destabilized GFP in either PB or non-PB
vectors. Tagged GFP signals from PB vectors were
much more robust than those from non-PB controls
throughout embryonic development (Supplementary
Figure S1). In PB-GFP labeled hemi-spinal cords, GFP
positive cells consist of both progenitors in the ependymal
zone as well as postmitotic cells in mantle zone and mar-
ginal zone (Figure 1F and Supplementary Figure S1).
By contrast, in non-PB transgenic samples, GFP positive
cells are usually concentrated in the ventral motor
neurons at later developmental stages (Figure 1F and
Supplementary Figure S1). Thus, PB-mediated transposi-
tion allows persistent transgene expression in diﬀerent cell
types of the developing chicken spinal cord.
We next evaluated whether PB-mediated transposi-
tion has an adverse eﬀect on spinal cord development.
Approximately 90% of embryos survived at day 4 after
electroporation whether embryos were co-electroporated
with PB-GFP transposon and PBase or with PB-GFP
transposon alone. Immunostaining of precursor marker
(Sox2), motor neuron marker (Islet 1/2), interneuron
marker (Nkx2.2) and diﬀerentiation marker (NF)
showed that stable integration of PB-GFP transgenes
did not alter spinal cord development at E8 or E20
(Supplementary Figure S2), thus allowing us to further
explore the application of PB in the chicken spinal cord.
Temporal regulation of PB transgene expression
Constitutive early activation of transgene expression
might preclude analysis of late developmental events.
Therefore, we decided to establish temporal regulation of
PB transgene expression using a previously characterized
ERT2CreERT2-loxP inducible system (28). Because
multiple copies of PB transposon can simultaneously
integrate into diﬀerent loci of the host genome, we con-
structed two independent PB transposons that express
ERT2CreERT2 and ﬂoxed GFP reporter, respectively
(Figure 2A). By introducing these two PB transposons
with PBase into the chicken spinal cord, ERT2CreERT2-
mediated excision led to tightly controlled GFP expres-
sion by 4-hydroxytamaxofen (4-OHT) administration at
speciﬁc developmental stages (Figure 2B) with virtually
no leaky GFP expression observed. Residual red ﬂuores-
cent signals after 4-OHT induction were likely due to the
stability of DsRed proteins (Figure 2B). When a similar
experiment was performed with Ff-luc ﬂoxed GFP
reporter, Ff-luc signals were mostly lost after 7-day treat-
ment with 4-OHT (Supplementary Figure S3). Thus, our
results indicate that ERT2CreERT2-loxP based binary PB
systems robustly regulate the onset of transgene expres-
sion in chicken embryos.
Cell-type-speciﬁc control of PB transgene expression
Approaches to label-speciﬁc cell types are highly desirable
for genetic studies of neural development. Therefore, we
asked whether we could use PB transposon system to label
a speciﬁc cell type during development. Glial ﬁbrillary
acidic protein (GFAP) is an intermediate ﬁlament
protein expressed almost exclusively in astrocytes. GFAP
normally begins to express during late embryonic devel-
opment. Thus, in the chicken spinal cord, GFAP expres-
sion is detectable at E15 and become more robust at E19
and E21 (Figure 3B, left panels). The 3-kb upstream
sequences of gfap genes from diﬀerent vertebrate species
are highly conserved and the gfap promoter is known to
direct astrocyte-speciﬁc expression even across diﬀerent
species (29). Because GFAP is expressed in astrocytes
late in development, conventional plasmid electroporation
is unlikely to yield cell-speciﬁc expression (Figure 3B,
middle panels). Thus, we constructed a PB transposon in
which GFP is under the control of 2.7-kb mouse gfap
promoter (Figure 3A). When introduced by electro-
poration with PBase, robust GFP expression was concom-
itant with the endogenous GFAP (Figure 3B, right
panels). All GFP positive cells are positive for endogenous
GFAP (Figure 3C); however, not all GFAP cells are
positive for GFP. This is likely due to that PB transposi-
tion is <100% after electroporation. Alternatively, the
proximal GFAP promoter might lack additional regula-
tory element for a subset of GFAP-expressing cells. Thus,
PB-gfap-GFP is expressed in an astrocyte-speciﬁc manner
in the chicken spinal cord, demonstrating the utility of PB
transposon to achieve cell-type-speciﬁc transgene
expression.
Transcription factors that specify diﬀerent neuronal
subtypes in the spinal cord have been well characterized
(30–33). Many cell-type-speciﬁc transcription factors are
transiently expressed in a subpopulation of precursor cells
at a speciﬁc developmental stage. At later developmental
stages, expression of a given transcription factor might be
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subtype. Therefore, we next developed a Cre-loxP based
strategy to label-speciﬁc neuronal subtypes. In this design,
a cell-type-speciﬁc promoter is used to drive Cre expres-
sion transiently in a subset of progenitors. Upon Cre
expression, excision of a ﬂoxed reporter PB transgene
gives rise to a permanent marker in daughter cells for
cell lineage analysis (Figure 4A). It has been shown that
Stem cell leukemia (Scl), a bHLH transcription factor,
is expressed and required for speciﬁcation of V2b
interneurons in the spinal cord (34,35). Importantly, the
conserved enhancer and promoter elements of Scl gene
have been characterized in both chicken and mammals
(36,37). Therefore, to test our strategy, we constructed a
modiﬁed 50Scl-Cre transgene (named  7E3/Cre)a s
described previously (36) (Figure 4A). When  7E3/Cre
transgene was coelectroporated with a Cre reporter,
PB-CAG-loxP-Luc-loxP-EGFP, a small number of inter-
neurons were labeled with GFP in the ventral spinal cord
(Figure 4B). Because majority of V2b interneurons
coexpress Scl, GATA2 and GATA3 transcription factors
during early embryonic stage and Scl antibodies suitable
for immunohistochemistry are not available (34,38), we
double-labeled cells for GATA3 and GFP to conﬁrm
that a majority of GFP positive cells were indeed
GATA3-positive at E6 (Figure 4C), indicating  7E3/Cre
is speciﬁcally expressed in V2b interneurons.
We next analyzed the overall projection patterns of V2b
interneurons using  7E3/Cre and the PB-CAG-loxP-Luc-
loxP-EGFP reporter. We found that Scl-expressing cells
comprise a heterogeneous population of neurons that
exhibit complex projection patterns (Figure 4D–F).
Some neuronal processes of Scl-expressing cells project
contralaterally across the midline (Figure 4F: a and b,
for transverse sections and c, for longitudinal sections)
while other V2b axons appear to project both rostrally
and caudally along the ipsilateral side of the spinal cord
(see red arrow in Figure 4F: d, for branches and red
asterisk in Fig. 4F: e, for a rostral growth cone). The
overall projection patterns obtained by directly visualizing
 7E3/Cre labeled neurons are consistent with known
early ipisilateral axonal projection patterns obtained by
ﬂuorescein detran retrograde labeling of GATA2/3
positive cells (39). In addition, our direct GFP labeling
method enables us to observe contralateral projections
of neuronal processes across the midline that were not
previously found with V2b interneurons. Thus, in combi-
nation with a PB-ﬂoxed reporter, a cell-speciﬁc Cre
transgene provides a speciﬁc and sensitive way to visualize
neuronal projection patterns.
PB-mediated stable RNAi in the chicken spinal cord
Transient electroporation of siRNA duplexes or shRNA
plasmids have been used to study early spinal cord devel-
opment (40,41). The stability of PB transgenes allows us to
expand this line of loss-of-function study to late neural
developmental events. To facilitate the use of stable
RNAi in the chicken embryos, we developed a PB
transposon that consists of human H1 promoter to
express shRNA and CAG-EGFP to label transfected
cells (Figure 5A). When PB-CAG-EGFP-H1-luc shRNA
that expresses a control shRNA against Ff luciferase was
stably transfected in the chicken spinal cord, motor axons
innervating gastrocnemius muscle ﬁbers were robustly
Figure 2. Temporal control of PB transgene expression. (A) ERT2CreERT2 regulated transgene expression. Upon 4-OHT induction, excision of
ﬂoxed DsRed leads to expression of EGFP. (B) A scheme of experimental design. EP: electroporation. (C) GFP expression is tightly regulated by
4-OHT induction during development. Bars are 100mm.
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leads to an obvious NMJ defect in the mouse (42), we
chose agrin as an example to test the eﬀectiveness of
stable RNAi. We synthesized ﬁve pairs of agrin shRNAs
against a common region of diﬀerently spliced chicken
agrin transcripts (43). Using a luciferase construct that
contains the agrin target sequences, we screened agrin
shRNAs and identiﬁed the most eﬀective shRNA
construct (Supplementary Figure S3). We then introduced
a stable PB-agrin-shRNA transgene into chicken neural
tubes by electroporation with PBase and found the agrin
mRNA levels were signiﬁcantly down-regulated in the
electroporation sides of the spinal cord by both RT-
PCR and in situ hybridization techniques (Figure 5C
and D). At later developmental stage E21, we visualized
NMJ maturation in gastrocnemius muscle ﬁbers by
confocal microcopy. As expected, knock-down of agrin
in spinal motor neurons by PB-agrin-shRNA caused
abnormal NMJ formation. In agrin-shRNA expressed
samples, acetylcholine receptor (AChR) clusters are
fewer and more dispersed at the end-plate band
(Figure 5E, lower panels) in comparison with a control
(Figure 5E, upper panels). A stable shRNA transgene
against agrin is able to recapitulate the NMJ defect seen
in agrin knock-out mice. Thus, PB-mediated stable RNAi
opens an avenue to perform loss-of-function studies on
late neural developmental processes such as NMJ matu-
ration in the chicken embryos.
DISCUSSION
In this study, we have shown that PB based transgenic
approaches are highly eﬃcient and versatile. The diverse
PB transgenic constructs described here provide a starting
point to implement this technique to perform gain-
of-function and loss-of-function studies of late neural
Figure 3. Labeling of astrocytes by a PB transgene. (A) Schematic of the mouse gfap gene and PB-gfap-EGFP transgene. (B)P B -gfap-EGFP
speciﬁcally labels GFAP positive cells at late stages of spinal cord development. At E19 or E21, robust GFP signals are seen in regions where
astrocytes reside. (C) High-magniﬁcation images showing that GFP is co-expressed in GFAP-positive astrocytes in both grey matter and white matter
of the spinal cord. Note that GFP and endogenous GFAP signals are not completely overlapped in GFP-positive cells because of their diﬀerent
subcellular localizations. Bars are 50mm in (B).
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transposon has important advantages over other
methods in the chick. First, unlike plasmid electro-
poration, the PB transposon system allows stable, long-
term expression of transgenes. Second, PB transposons
can accommodate DNA inserts up to 18kb circumventing
the DNA size limit of avian retroviral RCAS system. The
large capacity of PB transposons permits the independent
regulation of multiple transcripts from one vector. Third,
an electroporation based PB transgenic approach allows
very rapid transgene expression in comparison with a
recombinant lentiviral system. It usually takes 16h for
a lentivirus-transduced transgene to be expressed (44).
Fourth, PB system is compatible with heterologous
promoters and Cre/loxP technology and therefore
permits temporal and cell-type-speciﬁc regulation of
transgene expression. Fifth, PB transgenes that stably
express shRNAs allow loss-of-function studies of late
developmental events. Although a similar approach has
been reported using the Tol2 transposon system in
chicken embryos (45–47), a comparison of SB and PB
transposons shows that PB is the most eﬃcient transposon
in cultured mammalian cells (23) and chicken cells (data
not shown). Collectively, these characteristics make this
PB based transgenic system superior to other methods
for genetic analysis of chick neural development. The
Figure 4. PB-mediated labeling of V2b interneurons in the spinal cord. (A) A strategy to trace Scl-expressing cell lineage using PB transgenics. The
 7E3/Cre transgene that consists of mouse 50Scl promoter sequences transiently express Cre in Scl-expressing progenitors. Cre-mediated excision
leads to GFP expression from PB-loxP-luc-loxP-EGFP reporter. Scl-expressing cells are permanently labeled with GFP because the PB reporter is
stably integrated in the progenitors. (B) Activation of GFP expression by  7E3/Cre transgene in the chicken spinal cord. (C) GATA3 partially
overlaps GFP positive cells labeled by  7E3/Cre transgene. (D) Schematic illustration of the projection patterns of V2b (Scl-expressing) interneurons
in the spinal cord. The orientation of spinal cord and focal planes of confocal images of panel F a–e are marked. Turquoise: transverse section;
Purple: longitudinal section. (E) A single Scl-expressing neuron labeled by GFP on a transverse spinal cord section. (F) The projection patterns of
neuronal processes from GFP labeled V2b interneurons. a and b, transverse sections; c–e, longitudinal sections. Blue dotted line, midline. Bars are
100mm in (F).
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the study of other neuronal circuits in the chick, such as in
the cerebellum or the visual system. Indeed, PB vectors
have been successfully used to express large cDNAs such
as DSCAM and Sidekicks in chick retina (48).
When PB transposons are used in combination with
Cre-loxP recombination, one concern might be that Cre
could induce deleterious chromosomal deletion, inversion
and translocation between multiple loxP-containing
transposons that are integrated into the genome.
However, this does not appear to be a big concern for
three reasons. First, although it is diﬃcult to determine
the number of PB transposons per cell in postmitotic
spinal neurons, it is feasible to control the number of inte-
gration sites by titrating the amount of PB and PBase
expression vectors (21). Second, PB transposons
randomly integrate among 64 68 chicken chromosomes
throughout the whole genome. Therefore, multiple PB
Figure 5. Stable RNAi using a PB transgene. (A) Schematic of a PB transposon expressing shRNA. (B) Motor axons that innervate gastrocnemius
muscles are labeled with GFP at E21. (C) Semi-quantitative RT-PCR analysis shows that agrin is down-regulated in the electroporated sides (E) in
comparison with control sides (C) in agrin-shRNA electroporated spinal cords. Ff-luc shRNA serves as a negative control. Two independent embryo
(1 and 2) are shown. (D) In situ hybridization showing that agrin transcripts (red signals) are knock-down in the ventricular zone and ventral horn in
the electroporated side of the spinal cord. DAPI: blue. The midline is marked in yellow to distinguish non-electroporated and electroporated sides.
(E) Agrin knock-down by PB-shRNA induced abnormal NMJ maturation in gastrocnemius muscles. In chicken embryos electroporated with agrin
shRNA2472, AChR clusters are less dense and smaller at the end-plate band of gastrocnemius muscles (lower panels), while AChR clusters are
bigger and concentrated at nerve terminals in controls (upper panels). Motor axons and AChR clusters are visualized by GFP signals (green) and
Texas red conjugated a-bungatoxin (a-BT) staining (red), respectively. Shown are maximum intensity projections of stacks of 2mm images taken from
40–50mm muscle bundles.
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shown that Cre-loxP recombination in trans is very
ineﬃcient that occurs at an  0.1% frequency of cis-
recombination events (49,50). Therefore, Cre-induced
chromosomal abnormality should be rare. Third, individ-
ual transfected cells in a complex pool likely have
completely diﬀerent PB integration sites, thus rare chro-
mosomal abnormality would only happen in a very small
population of transfected cells. At the practical level, this
could be overcome by increasing sample size.
There are a couple of avenues to expand the utility of
PB system. Combined with other gene deliver methods,
for example, in utero electroporation (51), PB transposon
may also be used to achieve stable or cell-speciﬁc
transgene expression in mouse embryos. Because the
PB transposon can accommodate large DNA inserts and
the PB vector is fully compatible with the BAC
recombineering technique (52), it would be advantageous
to develop a panel of cell-type-speciﬁc promoters in PB
vectors to label distinct neuronal subtypes during devel-
opment. Meanwhile, it would also be a useful to construct
a variety of Cre-expressing BAC transgenes that can label-
speciﬁc cell types in conjunction with a ﬂoxed PB reporter.
Accumulation of these reagents will signiﬁcantly enhance
our ability to perform cell-speciﬁc genetic manipulation
using PB transgenic approaches.
Novel Brainbow transgenic mice have recently been
pioneered to achieve the color-coding of individual cells
through combinatorial expression of several ﬂuorescent
proteins (XFP) by stochastic action of Cre-loxP recombi-
nation (2). Conceptually, similar PB transposons that
consist of Brainbow transgenes can be used to label indi-
vidual neurons in conjunction with a Cre-expressing
transgene (e.g. PB-CAG-ERT2CreERT2) by electropora-
tion in ovo or in utero. Due to the large insert size that
a PB can accommodate, it is feasible construct such a
PB-Brainbow transgene. More importantly, if successful,
PB application can simplify and increase the throughput
of Brainbow transgenic approaches for mapping neuronal
circuits in the brain.
For the vertebrate central nervous system, details
of circuit maps and the genetic basis underlying circuit
development have been largely missing. The idea of
‘connectomics’ to apply large-scale approaches to neural
circuit mapping has been recently proposed (53). The
development of PB transgenics described here is a new
addition to the toolbox for such eﬀorts.
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